Conversion Study of Hepatocellular Carcinoma Using HAIC Combined with Lenvatinib and PD-1/L1 Immunotherapy under the Guidance of BCLC Staging
Frontiers in immunology（2025）
Key words
unresectable hepatocellular carcinoma,hepatic arterial infusion chemotherapy,lenvatinib,immunotherapy,conversion
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined